TY - JOUR
T1 - Monitoring neonates for ototoxicity
AU - Garinis, Angela C.
AU - Kemph, Alison
AU - Tharpe, Anne Marie
AU - Weitkamp, Joern Hendrik
AU - McEvoy, Cynthia
AU - Steyger, Peter S.
N1 - Funding Information:
This research was funded by National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR000128 to the Oregon Clinical and Translational Research Institute (PSS, ACG); by National Institute on Deafness and other Communication Disorders R01s DC004555, DC012588 (PSS); the U.S. Department of Education (H325K120305; for AMT), and the U.S. Maternal Child Health Bureau (T73MC00050; for AMT). The content is solely the responsibility of the authors and does not necessarily represent the official views of the above-listed federal agencies.
Publisher Copyright:
© 2017, © 2017 British Society of Audiology, International Society of Audiology, and Nordic Audiological Society.
PY - 2018/8/24
Y1 - 2018/8/24
N2 - Objectives: Neonates admitted to the neonatal intensive care unit (NICU) are at greater risk of permanent hearing loss compared to infants in well mother and baby units. Several factors have been associated with this increased prevalence of hearing loss, including congenital infections (e.g. cytomegalovirus or syphilis), ototoxic drugs (such as aminoglycoside or glycopeptide antibiotics), low birth weight, hypoxia and length of stay. The aetiology of this increased prevalence of hearing loss remains poorly understood. Design: Here we review current practice and discuss the feasibility of designing improved ototoxicity screening and monitoring protocols to better identify acquired, drug-induced hearing loss in NICU neonates. Study sample: A review of published literature. Conclusions: We conclude that current audiological screening or monitoring protocols for neonates are not designed to adequately detect early onset of ototoxicity. This paper offers a detailed review of evidence-based research, and offers recommendations for developing and implementing an ototoxicity monitoring protocol for young infants, before and after discharge from the hospital.
AB - Objectives: Neonates admitted to the neonatal intensive care unit (NICU) are at greater risk of permanent hearing loss compared to infants in well mother and baby units. Several factors have been associated with this increased prevalence of hearing loss, including congenital infections (e.g. cytomegalovirus or syphilis), ototoxic drugs (such as aminoglycoside or glycopeptide antibiotics), low birth weight, hypoxia and length of stay. The aetiology of this increased prevalence of hearing loss remains poorly understood. Design: Here we review current practice and discuss the feasibility of designing improved ototoxicity screening and monitoring protocols to better identify acquired, drug-induced hearing loss in NICU neonates. Study sample: A review of published literature. Conclusions: We conclude that current audiological screening or monitoring protocols for neonates are not designed to adequately detect early onset of ototoxicity. This paper offers a detailed review of evidence-based research, and offers recommendations for developing and implementing an ototoxicity monitoring protocol for young infants, before and after discharge from the hospital.
KW - Newborn hearing screening
KW - anatomy and physiology
KW - conditions/pathology/disorders
KW - paediatric
UR - http://www.scopus.com/inward/record.url?scp=85021061846&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85021061846&partnerID=8YFLogxK
U2 - 10.1080/14992027.2017.1339130
DO - 10.1080/14992027.2017.1339130
M3 - Article
C2 - 28949262
AN - SCOPUS:85021061846
SN - 1499-2027
VL - 57
SP - S41-S48
JO - International journal of audiology
JF - International journal of audiology
IS - sup4
ER -